Pexa AB engages in the development and commercialization of technology in the field of respiratory medicine. It provides lung researchers with a simple and non-invasive method for collection of microscopic particles, potential biomarkers for diseases in the small airways. The company was founded by Anna-Carin Olin in 2010 and is headquartered in Gothenburg, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company